Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

 

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

Eva Tseng, M.D., M.P.H.

Headshot of Eva Tseng
  • Assistant Professor of Medicine
Female

Languages: English, Mandarin

Expertise

Internal Medicine

Research Interests

Diabetes prevention; obesity prevention

Request an Appointment

Insurance Information

Main Phone

410-955-0670

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 410-955-0670
10753 Falls Road
Pavilion II Suite 325
Lutherville, MD 21093 map
Phone: 410-583-2774 | Fax: 410-583-2883

Background

Dr. Tseng is an Assistant Professor of Medicine in the Division of General Internal Medicine at Johns Hopkins School of Medicine. She completed her MD and MPH degree at Tufts University School of Medicine. She then completed internal medicine residency at Jefferson University Hospital. Subsequently, Dr. Tseng completed a General Internal Medicine Fellowship at Johns Hopkins. 

Dr. Tseng spends her time taking care of patients at the General Internal Medicine Clinic at Green Spring Station and conducting research. Her research focus is on how to improve diabetes prevention in the primary care setting. 

...read more

Titles

  • Assistant Professor of Medicine

Departments / Divisions

Education

Degrees

  • MD MPH; Tufts University School of Medicine (2011)

Residencies

  • Internal Medicine; Thomas Jefferson University Hospital (2014)

Fellowships

  • Internal Medicine; Johns Hopkins University School of Medicine (2017)

Research & Publications

Selected Publications

Maruther NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S. “Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis.” Ann Intern Med. 2016 Apr 19. doi: 10.7326/M15-2650. [Epub ahead of print]

Is this you? Edit Profile
back to top button